Rare diseases: Telethon-Cariplo funds two research projects at HT
Two research projects from Human Technopole have won the Fondazione Telethon and Cariplo grant to uncover the genetic and molecular mechanisms of acute myeloid leukemia and congenital adrenal hyperplasia. The projects, led by Alice Giustacchini (Group Leader of Genomics) and Emanuele Villa and Nicolò Caporale (Testa Group, Neurogenomics), have been respectively funded with €230,000 and €250,000.
The Telethon-Cariplo initiative aims to “illuminate the darkest portion of the human genome,” inviting researchers to study the so-called “T-dark targets,” namely genetic aspects and molecular mechanisms that are still largely unknown or poorly understood but represent potential for the development of new therapies for rare diseases.
Alice Giustacchini‘s research project will focus on defining the role of the poorly understood LNP1 protein in pediatric Acute Myeloid Leukemia, a rare but highly aggressive form of blood cancer. At the core of this pathology lies an enigma involving damaged genes “glued” together in the wrong way. One gene in particular, known as NUP98, often tends to fuse with other genes, giving rise to so-called “fusion genes”, which can drive cells towards uncontrolled growth and, ultimately, cancer. In this context, the LNP1 protein remains shrouded in mystery, as its role and functions are unknown. The Giustacchini Group, in collaboration with Ruggiero Norfo (University of Modena and Reggio Emilia), will use multi-scale approaches to uncover new insights into biological mechanisms of malignant transformation.
“Understanding this mysterious gene could provide valuable clues for the development of therapies, offering hope to those affected by this rare but devastating disease,” says Giustacchini.
Emanuele Villa‘s project, together with Nicolò Caporale (Università degli Studi di Milano La Statale), aims to study the involvement of the hormonal modulator SP5 in the congenital adrenal hyperplasia. This group of genetic diseases is characterized by insufficient production of two important hormones derived from cholesterol, from prenatal development stages, due to the deficiency of the enzyme 21-hydroxylase, which increases the patients’ risk of neurodevelopmental disorders and of a particular form of testicular tumors. Building on hormone studies conducted through experimental models based on human stem cells and organoids, the Testa Group aims to give a translational impact to research in this field through experimental investigation of exposure to hormonal modulators, particularly SP5, a transcription factor still poorly understood.
“Through the modulation of SP5, we will test the opportunity to reverse molecular and cellular phenotypes and propose new approaches to treating patients’ clinical symptoms,” emphasizes Emanuele Villa.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.